Clinical Trial Update: Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating AZD4547 in FGFR1/FGFR2-amplified tumors, including gastric cancer, esophageal cancer, breast cancer, and squamous cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Cancer
• Gastric Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• AZD4547

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Gastric Cancer, Oesophageal Cancer | Phase 2 | Status: UNKNOWN